{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:32:05Z","timestamp":1788503525584,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110679"],"award-info":[{"award-number":["W81XWH2110679"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health","award":["5R01 AR077574"],"award-info":[{"award-number":["5R01 AR077574"]}]},{"name":"National Institute of Health","award":["HL119225"],"award-info":[{"award-number":["HL119225"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS099850"],"award-info":[{"award-number":["NS099850"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Duchenne muscular dystrophy (DMD) is a progressive and devastating muscle disease, resulting from the absence of dystrophin. This leads to cell membrane instability, susceptibility to contraction-induced muscle damage, subsequent muscle degeneration, and eventually disability and early death of patients. Currently, there is no cure for DMD. Our recent studies identified that lipin1 plays a critical role in maintaining myofiber stability and integrity. However, lipin1 gene expression levels are dramatically reduced in the skeletal muscles of DMD patients and mdx mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To identify whether increased lipin1 expression could prevent dystrophic pathology, we employed unique muscle-specific mdx:lipin1 transgenic (mdx:lipin1\n                      <jats:sup>Tg\/0<\/jats:sup>\n                      ) mice in which lipin1 was restored in the dystrophic muscle of mdx mice, intramuscular gene delivery, as well as cell culture system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that increased lipin1 expression suppressed muscle degeneration and inflammation, reduced fibrosis, strengthened membrane integrity, and resulted in improved muscle contractile and lengthening force, and muscle performance in mdx:lipin1\n                      <jats:sup>Tg\/0<\/jats:sup>\n                      compared to mdx mice. To confirm the role of lipin1 in dystrophic muscle, we then administered AAV1-lipin1 via intramuscular injection in mdx mice. Consistently, lipin1 restoration inhibited myofiber necroptosis and lessened muscle degeneration. Using a cell culture system, we further found that differentiated primary mdx myoblasts had elevated expression levels of necroptotic markers and medium creatine kinase (CK), which could be a result of sarcolemmal damage. Most importantly, increased lipin1 expression levels in differentiated myoblasts from mdx:lipin1\n                      <jats:sup>Tg\/0<\/jats:sup>\n                      mice substantially inhibited the elevation of necroptotic markers and medium CK levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, our data suggest that lipin1 is a promising therapeutic target for the treatment of dystrophic muscles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-024-05494-z","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T13:02:03Z","timestamp":1721134923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"22","author":[{"given":"Abdulrahman","family":"Jama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Alshudukhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Karanja","family":"Kamau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooklyn","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A.","family":"Alkhomsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian N.","family":"Finck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Alvin","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0210-1502","authenticated-orcid":false,"given":"Hongmei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"issue":"10","key":"5494_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","volume":"21","author":"SJ Moat","year":"2013","unstructured":"Moat SJ, Bradley DM, Salmon R, Clarke A, Hartley L. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur J Hum Genet. 2013;21(10):1049\u201353.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"5494_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell JR, Shilling C, Leslie ND, Flanigan KM, Al-Dahhak R, Gastier-Foster J, et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012;71(3):304\u201313.","journal-title":"Ann Neurol"},{"issue":"1","key":"5494_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis. 2017;12(1):79.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"5494_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, Van Ommen GJB, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34(2):135\u201344.","journal-title":"Muscle Nerve"},{"issue":"1","key":"5494_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77\u201393.","journal-title":"Lancet Neurol"},{"issue":"4","key":"5494_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1183\/09031936.05.00031304","volume":"25","author":"J Gonzalez-Bermejo","year":"2005","unstructured":"Gonzalez-Bermejo J, Lofaso F, Falaize L, Lejaille M, Raphael JC, Similowski T, et al. Resting energy expenditure in Duchenne patients using home mechanical ventilation. Eur Respir J. 2005;25(4):682\u20137.","journal-title":"Eur Respir J"},{"key":"5494_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/485376","volume":"2012","author":"ODC Guzman","year":"2012","unstructured":"Guzman ODC, Garcia ALC, Rodriguez-Cruz M. Muscular dystrophies at different ages: metabolic and endocrine alterations. Int J Endocrinol. 2012;2012:1\u201312.","journal-title":"Int J Endocrinol."},{"issue":"4","key":"5494_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1083\/jcb.201212142","volume":"201","author":"F Rahimov","year":"2013","unstructured":"Rahimov F, Kunkel LM. The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol. 2013;201(4):499\u2013510.","journal-title":"J Cell Biol"},{"issue":"1","key":"5494_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/humc.2016.001","volume":"27","author":"D Duan","year":"2016","unstructured":"Duan D. Dystrophin gene replacement and gene repair therapy for Duchenne muscular dystrophy in 2016: an interview. Hum Gene Ther Clin Dev. 2016;27(1):9\u201318.","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"25","key":"5494_CR10","doi-asserted-by":"publisher","first-page":"13714","DOI":"10.1073\/pnas.240335297","volume":"97","author":"B Wang","year":"2000","unstructured":"Wang B, Li J, Xiao X. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci USA. 2000;97(25):13714\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"5494_CR11","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","volume":"26","author":"D Duan","year":"2018","unstructured":"Duan D, Systemic AAV. Micro-dystrophin gene therapy for Duchenne muscular dystrophy. Mol Ther. 2018;26(10):2337\u201356.","journal-title":"Mol Ther"},{"issue":"15","key":"5494_CR12","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/hmg\/10.15.1547","volume":"10","author":"JC van Deutekom","year":"2001","unstructured":"van Deutekom JC, Bremmer-Bout M, Janson AA, Ginjaar IB, Baas F, den Dunnen JT, et al. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet. 2001;10(15):1547\u201354.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5494_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1073\/pnas.98.1.42","volume":"98","author":"CJ Mann","year":"2001","unstructured":"Mann CJ, Honeyman K, Cheng AJ, Ly T, Lloyd F, Fletcher S, et al. Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci USA. 2001;98(1):42\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"5494_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.21627","volume":"65","author":"T Yokota","year":"2009","unstructured":"Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, Takeda S, et al. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol. 2009;65(6):667\u201376.","journal-title":"Ann Neurol"},{"issue":"20","key":"5494_CR15","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14620","volume":"8","author":"S Ramani Sattiraju","year":"2020","unstructured":"Ramani Sattiraju S, Jama A, Alshudukhi AA, Edward Townsend N, Reynold Miranda D, Reese RR, et al. Loss of membrane integrity drives myofiber death in lipin1-deficient skeletal muscle. Physiol Rep. 2020;8(20): e14620.","journal-title":"Physiol Rep"},{"key":"5494_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1113\/JP284085","volume":"601","author":"A Jama","year":"2023","unstructured":"Jama A, Alshudukhi AA, Burke S, Dong L, Kamau JK, Voss AA, et al. Lipin1 plays complementary roles in myofiber stability and regeneration in dystrophic muscles. J Physiol. 2023;601:961\u201378.","journal-title":"J Physiol"},{"issue":"14","key":"5494_CR17","doi-asserted-by":"publisher","first-page":"9210","DOI":"10.1074\/jbc.M600425200","volume":"281","author":"GS Han","year":"2006","unstructured":"Han GS, Wu WI, Carman GM. The Saccharomyces cerevisiae lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. J Biol Chem. 2006;281(14):9210\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"5494_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/sj.embor.7400378","volume":"6","author":"A Toker","year":"2005","unstructured":"Toker A. The biology and biochemistry of diacylglycerol signaling. Meeting on molecular advances in diacylglycerol signalling. EMBO Rep. 2005;6(4):310\u20134.","journal-title":"EMBO Rep"},{"key":"5494_CR19","first-page":"S56","volume":"33","author":"C Michot","year":"2010","unstructured":"Michot C, Hubert L, Brivet M, De Meirleir L, Valayannopoulos V, Muller-Felber W, et al. Lpin1 gene mutations: a major cause of severe rhabdomyolysis in early childhood. J Inherit Metab Dis. 2010;33:S56.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"5494_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1096\/fj.201800361R","volume":"33","author":"GG Schweitzer","year":"2019","unstructured":"Schweitzer GG, Collier SL, Chen Z, McCommis KS, Pittman SK, Yoshino J, et al. Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice. FASEB J. 2019;33(1):652\u201367.","journal-title":"FASEB J"},{"issue":"12","key":"5494_CR21","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1096\/fj.201800374","volume":"32","author":"AA Alshudukhi","year":"2018","unstructured":"Alshudukhi AA, Zhu J, Huang DT, Jama A, Smith JD, Wang QJ, et al. Lipin-1 regulates Bnip3-mediated mitophagy in glycolytic muscle. FASEB J. 2018;32(12):6796\u2013807.","journal-title":"FASEB J"},{"issue":"2","key":"5494_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2014.05.003","volume":"20","author":"P Zhang","year":"2014","unstructured":"Zhang P, Verity MA, Reue K. Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle. Cell Metab. 2014;20(2):267\u201379.","journal-title":"Cell Metab"},{"issue":"1","key":"5494_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899576","volume":"38","author":"T Rashid","year":"2019","unstructured":"Rashid T, Nemazanyy I, Paolini C, Tatsuta T, Crespin P, de Villeneuve D, et al. Lipin1 deficiency causes sarcoplasmic reticulum stress and chaperone-responsive myopathy. EMBO J. 2019;38(1): e99576.","journal-title":"EMBO J"},{"issue":"3","key":"5494_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1113\/JP276919","volume":"597","author":"A Jama","year":"2019","unstructured":"Jama A, Huang DT, Alshudukhi AA, Chrast R, Ren HM. Lipin1 is required for skeletal muscle development by regulating MEF2c and MyoD expression. J Physiol. 2019;597(3):889\u2013901.","journal-title":"J Physiol"},{"issue":"39","key":"5494_CR25","doi-asserted-by":"publisher","first-page":"23646","DOI":"10.1074\/jbc.M115.686519","volume":"290","author":"WH Jiang","year":"2015","unstructured":"Jiang WH, Zhu J, Zhuang X, Zhang XP, Luo T, Esser KA, et al. Lipin1 regulates skeletal muscle differentiation through extracellular signal-regulated kinase (ERK) activation and cyclin D complex-regulated cell cycle withdrawal. J Biol Chem. 2015;290(39):23646\u201355.","journal-title":"J Biol Chem"},{"key":"5494_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65691","volume":"10","author":"JH Myers","year":"2021","unstructured":"Myers JH, Denman K, DuPont C, Hawash AA, Novak KR, Koesters A, et al. The mechanism underlying transient weakness in myotonia congenita. Elife. 2021;10: e65691.","journal-title":"Elife"},{"issue":"5","key":"5494_CR27","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.201912526","volume":"152","author":"X Wang","year":"2020","unstructured":"Wang X, Burke SRA, Talmadge RJ, Voss AA, Rich MM. Depressed neuromuscular transmission causes weakness in mice lacking BK potassium channels. J Gen Physiol. 2020;152(5): e201912526.","journal-title":"J Gen Physiol"},{"issue":"6","key":"5494_CR28","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/fsn3.3337","volume":"11","author":"A Ahmad","year":"2023","unstructured":"Ahmad A, Nosheen F, Arshad MU, Saeed F, Afzaal M, Islam F, et al. Isolation and antioxidant characterization of theaflavin for neuroprotective effect in mice model. Food Sci Nutr. 2023;11(6):3485\u201396.","journal-title":"Food Sci Nutr"},{"issue":"6","key":"5494_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064525","volume":"8","author":"G Hussain","year":"2013","unstructured":"Hussain G, Schmitt F, Henriques A, Lequeu T, Rene F, Bindler F, et al. Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PLoS ONE. 2013;8(6): e64525.","journal-title":"PLoS ONE"},{"issue":"1","key":"5494_CR30","first-page":"178","volume":"7","author":"A Brown","year":"2023","unstructured":"Brown A, Morris B, Kaumau JK, Alshudukhi AA, Jam A, Ren H. Automated image analysis pipeline development to monitor disease progression in muscular dystrophy using cell profiler. Arch Microbio Immunol. 2023;7(1):178\u201387.","journal-title":"Arch Microbio Immunol."},{"issue":"4","key":"5494_CR31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cphy.c170052","volume":"8","author":"JG Tidball","year":"2018","unstructured":"Tidball JG, Welc SS, Wehling-Henricks M. Immunobiology of inherited muscular dystrophies. Compr Physiol. 2018;8(4):1313\u201356.","journal-title":"Compr Physiol"},{"issue":"11","key":"5494_CR32","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.15252\/emmm.201403967","volume":"6","author":"K Mojumdar","year":"2014","unstructured":"Mojumdar K, Liang F, Giordano C, Lemaire C, Danialou G, Okazaki T, et al. Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2. EMBO Mol Med. 2014;6(11):1476\u201392.","journal-title":"EMBO Mol Med"},{"issue":"17","key":"5494_CR33","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1111\/febs.12166","volume":"280","author":"M Saclier","year":"2013","unstructured":"Saclier M, Cuvellier S, Magnan M, Mounier R, Chazaud B. Monocyte\/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS J. 2013;280(17):4118\u201330.","journal-title":"FEBS J"},{"issue":"3","key":"5494_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/path.4301","volume":"232","author":"ML Novak","year":"2014","unstructured":"Novak ML, Weinheimer-Haus EM, Koh TJ. Macrophage activation and skeletal muscle healing following traumatic injury. J Pathol. 2014;232(3):344\u201355.","journal-title":"J Pathol"},{"key":"5494_CR35","doi-asserted-by":"crossref","first-page":"A548","DOI":"10.2337\/db09-0035","volume":"60","author":"SJ Burke","year":"2011","unstructured":"Burke SJ, Lu D, Becker TC, Bellich RM, Norwood J, Karlstad MD, et al. Regulation of the inducible nitric oxide synthase gene (iNOS) by cytokines requires phosphorylation of the p65 subunit of NF-KB at Ser276 and Ser536 and signal transducer and activator of transcription 1 (STAT1) at Tyr701. Diabetes. 2011;60:A548.","journal-title":"Diabetes"},{"issue":"1","key":"5494_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells5010012","volume":"5","author":"F Christian","year":"2016","unstructured":"Christian F, Smith EL, Carmody RJ. The regulation of NF-kappa B subunits by phosphorylation. Cells. 2016;5(1):12.","journal-title":"Cells"},{"issue":"1","key":"5494_CR37","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1038\/s41467-018-06057-9","volume":"9","author":"JE Morgan","year":"2018","unstructured":"Morgan JE, Prola A, Mariot V, Pini V, Meng J, Hourde C, et al. Necroptosis mediates myofibre death in dystrophin-deficient mice. Nat Commun. 2018;9(1):3655.","journal-title":"Nat Commun"},{"issue":"3","key":"5494_CR38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/jnen\/60.3.302","volume":"60","author":"M Sandri","year":"2001","unstructured":"Sandri M, El Meslemani AH, Sandri C, Schjerling P, Vissing K, Andersen JL, et al. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol. 2001;60(3):302\u201312.","journal-title":"J Neuropathol Exp Neurol"},{"key":"5494_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.691245","volume":"12","author":"S Krishna","year":"2021","unstructured":"Krishna S, Spaulding HR, Quindry TS, Hudson MB, Quindry JC, Selsby JT. Indices of defective autophagy in whole muscle and lysosome enriched fractions from aged D2-mdx mice. Front Physiol. 2021;12: 691245.","journal-title":"Front Physiol"},{"issue":"6","key":"5494_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/153537020422900608","volume":"229","author":"JM Lang","year":"2004","unstructured":"Lang JM, Esser KA, Dupont-Versteegden EE. Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice. Exp Biol Med. 2004;229(6):503\u201311.","journal-title":"Exp Biol Med"},{"issue":"Pt 14","key":"5494_CR41","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1242\/jcs.115.14.2801","volume":"115","author":"J Ehmsen","year":"2002","unstructured":"Ehmsen J, Poon E, Davies K. The dystrophin-associated protein complex. J Cell Sci. 2002;115(Pt 14):2801\u20133.","journal-title":"J Cell Sci"},{"key":"5494_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13395-015-0041-y","volume":"5","author":"W Duddy","year":"2015","unstructured":"Duddy W, Duguez S, Johnston H, Cohen TV, Phadke A, Gordish-Dressman H, et al. Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia. Skelet Muscle. 2015;5:16.","journal-title":"Skelet Muscle."},{"key":"5494_CR43","doi-asserted-by":"publisher","first-page":"1119888","DOI":"10.3389\/fimmu.2023.1119888","volume":"14","author":"B Boccanegra","year":"2023","unstructured":"Boccanegra B, Cappellari O, Mantuano P, Trisciuzzi D, Mele A, Tulimiero L, et al. Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy. Front Immunol. 2023;14:1119888.","journal-title":"Front Immunol"},{"issue":"1","key":"5494_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13395-020-0221-2","volume":"10","author":"A Lindsay","year":"2020","unstructured":"Lindsay A, Baumann CW, Rebbeck RT, Yuen SL, Southern WM, Hodges JS, et al. Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators. Skelet Muscle. 2020;10(1):3.","journal-title":"Skelet Muscle."},{"issue":"5","key":"5494_CR45","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ajpath.2013.01.020","volume":"182","author":"C Hourde","year":"2013","unstructured":"Hourde C, Joanne P, Medja F, Mougenot N, Jacquet A, Mouisel E, et al. Voluntary physical activity protects from susceptibility to skeletal muscle contraction-induced injury but worsens heart function in mdx mice. Am J Pathol. 2013;182(5):1509\u201318.","journal-title":"Am J Pathol"},{"issue":"6","key":"5494_CR46","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/cam4.1483","volume":"7","author":"X Fan","year":"2018","unstructured":"Fan X, Weng Y, Bai Y, Wang Z, Wang S, Zhu J, et al. Lipin-1 determines lung cancer cell survival and chemotherapy sensitivity by regulation of endoplasmic reticulum homeostasis and autophagy. Cancer Med. 2018;7(6):2541\u201354.","journal-title":"Cancer Med"},{"issue":"7","key":"5494_CR47","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1096\/fj.201601353R","volume":"31","author":"JQ He","year":"2017","unstructured":"He JQ, Zhang F, Tay LWR, Boroda S, Nian WQ, Levental KR, et al. Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival. FASEB J. 2017;31(7):2893\u2013904.","journal-title":"FASEB J"},{"issue":"2","key":"5494_CR48","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/mt.2011.237","volume":"20","author":"DE Bowles","year":"2012","unstructured":"Bowles DE, McPhee SW, Li C, Gray SJ, Samulski JJ, Camp AS, et al. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther. 2012;20(2):443\u201355.","journal-title":"Mol Ther"},{"issue":"3","key":"5494_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","volume":"4","author":"BN Finck","year":"2006","unstructured":"Finck BN, Gropler MC, Chen ZJ, Leone TC, Croce MA, Harris TE, et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1 alpha\/PPAR alpha regulatory pathway. Cell Metab. 2006;4(3):199\u2013210.","journal-title":"Cell Metab"},{"issue":"5","key":"5494_CR50","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1255\/ejms.671","volume":"10","author":"D Touboul","year":"2004","unstructured":"Touboul D, Piednoel H, Voisin V, De La Porte S, Brunelle A, Halgand F, et al. Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption\/ionization mass spectrometry and mass spectrometry imaging. Eur J Mass Spectrom (Chichester). 2004;10(5):657\u201364.","journal-title":"Eur J Mass Spectrom (Chichester)"},{"issue":"2","key":"5494_CR51","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1194\/jlr.M700421-JLR200","volume":"49","author":"N Tahallah","year":"2008","unstructured":"Tahallah N, Brunelle A, De La Porte S, Laprevote O. Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging. J Lipid Res. 2008;49(2):438\u201354.","journal-title":"J Lipid Res"},{"issue":"1","key":"5494_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1194\/jlr.R012120","volume":"53","author":"HK Saini-Chohan","year":"2012","unstructured":"Saini-Chohan HK, Mitchell RW, Vaz FM, Zelinski T, Hatch GM. Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: thematic review series: genetics of human lipid diseases. J Lipid Res. 2012;53(1):4\u201327.","journal-title":"J Lipid Res"},{"issue":"23","key":"5494_CR53","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.1128\/MCB.01187-07","volume":"27","author":"MJ Potthoff","year":"2007","unstructured":"Potthoff MJ, Arnold MA, McAnally J, Richardson JA, Bassel-Duby R, Olson EN. Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol Cell Biol. 2007;27(23):8143\u201351.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"5494_CR54","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1152\/ajpregu.00221.2012","volume":"305","author":"K Hollinger","year":"2013","unstructured":"Hollinger K, Gardan-Salmon D, Santana C, Rice D, Snella E, Selsby JT. Rescue of dystrophic skeletal muscle by PGC-1 alpha involves restored expression of dystrophin-associated protein complex components and satellite cell signaling. Am J Physiol Regul Integr Comp Physiol. 2013;305(1):R13\u201323.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5494_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2044-5040-4-2","volume":"4","author":"MC Chan","year":"2014","unstructured":"Chan MC, Rowe GC, Raghuram S, Patten IS, Farrell C, Arany Z. Post-natal induction of PGC-1 alpha protects against severe muscle dystrophy independently of utrophin. Skelet Muscle. 2014;4:2.","journal-title":"Skelet Muscle."},{"key":"5494_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/8904_2015_440","volume":"23","author":"GG Schweitzer","year":"2015","unstructured":"Schweitzer GG, Collier SL, Chen Z, Eaton JM, Connolly AM, Bucelli RC, et al. Rhabdomyolysis-associated mutations in human LPIN1 lead to loss of phosphatidic acid phosphohydrolase activity. JIMD Rep. 2015;23:113\u201322.","journal-title":"JIMD Rep."},{"issue":"1","key":"5494_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7(1):13.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"5494_CR58","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1152\/japplphysiol.00544.2014","volume":"117","author":"L Lacourpaille","year":"2014","unstructured":"Lacourpaille L, Hug F, Guevel A, Pereon Y, Magot A, Hogrel JY, et al. New insights on contraction efficiency in patients with Duchenne muscular dystrophy. J Appl Physiol. 2014;117(6):658\u201362.","journal-title":"J Appl Physiol"},{"issue":"7","key":"5494_CR59","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/NEN.0b013e3181aa31c2","volume":"68","author":"I Desguerre","year":"2009","unstructured":"Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol. 2009;68(7):762\u201373.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"5494_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(82)90220-9","volume":"54","author":"V Ionasescu","year":"1982","unstructured":"Ionasescu V, Ionasescu R. Increased collagen synthesis by Duchenne myogenic clones. J Neurol Sci. 1982;54(1):79\u201387.","journal-title":"J Neurol Sci"},{"issue":"1","key":"5494_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00314217","volume":"236","author":"D Cros","year":"1989","unstructured":"Cros D, Harnden P, Pellissier JF, Serratrice G. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol. 1989;236(1):43\u20137.","journal-title":"J Neurol"},{"issue":"2","key":"5494_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0022-510X(83)90071-0","volume":"60","author":"DA Jones","year":"1983","unstructured":"Jones DA, Round JM, Edwards RH, Grindwood SR, Tofts PS. Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and histochemical study. J Neurol Sci. 1983;60(2):307\u201322.","journal-title":"J Neurol Sci"},{"issue":"1","key":"5494_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pmr.2011.11.014","volume":"23","author":"JN Kornegay","year":"2012","unstructured":"Kornegay JN, Childers MK, Bogan DJ, Bogan JR, Nghiem P, Wang J, et al. The paradox of muscle hypertrophy in muscular dystrophy. Phys Med Rehabil Clin N Am. 2012;23(1):149\u201372.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"5","key":"5494_CR64","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/practneurol-2017-001695","volume":"17","author":"J Walters","year":"2017","unstructured":"Walters J. Muscle hypertrophy and pseudohypertrophy. Pract Neurol. 2017;17(5):369\u201379.","journal-title":"Pract Neurol"},{"issue":"4","key":"5494_CR65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/BF00121294","volume":"14","author":"C Pastoret","year":"1993","unstructured":"Pastoret C, Sebille A. Time course study of the isometric contractile properties of mdx mouse striated muscles. J Muscle Res Cell Motil. 1993;14(4):423\u201331.","journal-title":"J Muscle Res Cell Motil"},{"issue":"1","key":"5494_CR66","doi-asserted-by":"publisher","first-page":"17248","DOI":"10.1038\/s41598-020-74192-9","volume":"10","author":"RT Massopust","year":"2020","unstructured":"Massopust RT, Lee YI, Pritchard AL, Nguyen VM, McCreedy DA, Thompson WJ. Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss. Sci Rep. 2020;10(1):17248.","journal-title":"Sci Rep"},{"issue":"Pt 2","key":"5494_CR67","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-7793.2001.00591.x","volume":"535","author":"GS Lynch","year":"2001","unstructured":"Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV, Faulkner JA. Force and power output of fast and slow skeletal muscles from mdx mice 6\u201328 months old. J Physiol. 2001;535(Pt 2):591\u2013600.","journal-title":"J Physiol"},{"key":"5494_CR68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev.nutr.012809.104729","volume":"30","author":"LS Csaki","year":"2010","unstructured":"Csaki LS, Reue K. Lipins: multifunctional lipid metabolism proteins. Annu Rev Nutr. 2010;30:257\u201372.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"5494_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-021-01437-5","volume":"20","author":"LM Ingram","year":"2021","unstructured":"Ingram LM, Finnerty MC, Mansoura M, Chou CW, Cummings BS. Identification of lipidomic profiles associated with drug-resistant prostate cancer cells. Lipids Health Dis. 2021;20(1):15.","journal-title":"Lipids Health Dis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05494-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05494-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05494-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T14:01:57Z","timestamp":1721138517000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05494-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5494"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05494-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with the relevant guidelines and regulations approved by the Animal Care and Use Committee of Wright State University and approval was obtained for all experiments performed in this study (#1218 and #1206).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}